Buy & Sell Microchip Technology Inc. (MCHP) – Microchip Technology Inc. Price Today
Aura AI Summary
Key Stats
- $49.53BMarket Cap
- TechnologySector
- -14.21%3M Drawdown
- $54.82BEnterprise Value
- 1.99%Dividend Yield
- 18% Buy | 82% SellTrading Activity
- 61 daysTypical Hold Time
Microchip Technology Inc. (MCHP) is currently valued at a market capitalization of $49.53B, with an enterprise value of $54.82B. Over the past 52 weeks, Microchip Technology Inc. has traded between a low of $49.02 and a high of $102.97, highlighting its annual price range. Over the past three months, Microchip Technology Inc. has recorded a drawdown of -14.21%, reflecting recent price volatility. Microchip Technology Inc. offers a dividend yield of 1.99%, with the most recent dividend of $0.46 paid on 22 May 26. On average, investors hold Microchip Technology Inc. for approximately 61 days, indicating typical investor behavior on the platform.
About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Most Recent News
Lemonade launches affordable renters insurance in North Dakota starting at $5/month
Lemonade, a tech-driven insurance company, has expanded its renters insurance to North Dakota, offering fast, affordable coverage starting at $5 per month. The service allows renters to manage policies and claims via an app, with about 40% of claims ...

Momentus boosts cash to $76M, advances Vigoride 7 space mission, stock rebounds.
Momentus strengthened its financial position by raising cash to about $76 million through a fully utilized $50 million at-the-market program, a $25 million private placement, and warrant exercises. The company reported progress on its Vigoride 7 miss...

DBV Technologies revises participation at Goldman Sachs Global Healthcare Conference due to CEO travel issue.
DBV Technologies announced a change in its participation at the 47th Annual Global Healthcare Conference by Goldman Sachs, held on June 9, 2026, in Miami. The company's CEO, Daniel Tassé, will not attend the informal discussion as initially planned d...
